Welcome to the Emerging Pathogens & Infectious Diseases Consortium
Welcome to EPIC – the Emerging Pathogens and Infectious Diseases Consortium.
EPIC brings together researchers, clinicians, and institutions across the University of Toronto and its hospital partners to advance infectious disease research and build lasting resilience against emerging threats.
This work builds on a long legacy: EPIC partners have played an integral role in infectious disease research for a century, from work that helped control diphtheria and eradicate smallpox, to today’s front-line research in antimicrobial resistance and infection control. Our collective response to COVID-19, highly pathogenic avian influenza, and mpox makes clear there’s never been a more important time to advance that work, from emerging pathogens and antimicrobial resistance to health inequities and public trust.
Building on this momentum, EPIC marshals the advanced research infrastructure and world-renowned research and training expertise of our EPIC partners to deliver an integrated, innovative response to the infectious disease challenges facing communities today and in the future.
Seven EPIC research clusters
Antimicrobial Resistance
Protecting the effectiveness of the medicines we depend on.
Chronic Infections
Addressing the long-term burden of infections that don’t resolve.
Emerging Pathogens
Detecting and responding to new and re-emerging threats before they spread.
Health Inequities
Ensuring infectious disease research and response reach everyone, equitably.
Health Systems Resilience
Building health systems that bend, not break, under infectious threats.
Misinformation, Disinformation & Public Trust
Strengthening public trust through clear, credible information.
Sepsis & Acute Respiratory Distress
Improving detection and treatment when every minute counts.
EPIC News
Mpox DNA can persist in the body for up to four weeks: U of T study
From left to right: Robert Kozak, Sharmistha Mishra and Darrell Tan March 7, 2024 By Betty Zou A new University of Toronto study has found that mpox virus DNA can be found in different parts of the body for up to four weeks after symptom onset. The study, led by...
Alice Augusta Ball: The unrecognized chemist behind a breakthrough leprosy treatment
In honour of Black History Month, we are pleased to feature a series of stories celebrating the contributions Black individuals have made to our understanding of infectious diseases and how to prevent and treat them. Each story is written by a member of EPIC’s Trainee...
Jane Hinton: An early leader in our fight against antimicrobial resistance
In honour of Black History Month, we are pleased to feature a series of stories celebrating the contributions Black individuals have made to our understanding of infectious diseases and how to prevent and treat them. Each story is written by a member of EPIC’s Trainee...
